Bellevue Group AG - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2022$1,849,000
-0.9%
31,000
+20.6%
0.03%
+18.2%
Q1 2022$1,866,000
+5.7%
25,700
+22.4%
0.02%
+22.2%
Q4 2021$1,766,000
-29.8%
21,000
-24.7%
0.02%
-30.8%
Q3 2021$2,516,000
+23.3%
27,900
+30.4%
0.03%
+30.0%
Q2 2021$2,040,000
-56.3%
21,400
-47.8%
0.02%
-59.2%
Q1 2021$4,668,000
-17.8%
41,0000.0%0.05%
-24.6%
Q4 2020$5,676,000
+68.4%
41,0000.0%0.06%
+38.3%
Q3 2020$3,370,000
+79.5%
41,000
+70.8%
0.05%
+74.1%
Q2 2020$1,877,000
+96.5%
24,000
+11.6%
0.03%
+42.1%
Q1 2020$955,000
-34.0%
21,500
-5.7%
0.02%
-24.0%
Q2 2019$1,448,000
-29.9%
22,800
-23.5%
0.02%
-78.1%
Q1 2019$2,067,000
+114.2%
29,800
+34.2%
0.11%
+81.0%
Q4 2018$965,000
-60.3%
22,200
-30.3%
0.06%
-59.1%
Q3 2018$2,431,000
-19.2%
31,850
-18.6%
0.15%
-40.1%
Q2 2018$3,009,000
+46.4%
39,150
-2.9%
0.26%
+26.0%
Q1 2018$2,055,000
+8.3%
40,300
-1.5%
0.20%
+3.0%
Q4 2017$1,897,000
-15.2%
40,900
-2.6%
0.20%
-15.4%
Q3 2017$2,237,000
+38.5%
42,0000.0%0.23%
+22.5%
Q2 2017$1,615,000
-43.3%
42,0000.0%0.19%
-49.6%
Q1 2017$2,847,000
-5.8%
42,000
-2.3%
0.38%
-38.8%
Q4 2016$3,023,000
-0.9%
43,0000.0%0.62%
+12.3%
Q3 2016$3,050,000
+122.8%
43,000
+53.6%
0.55%
+113.6%
Q2 2016$1,369,000
+116.3%
28,000
+180.0%
0.26%
+124.3%
Q1 2016$633,00010,0000.12%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2016
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders